Thermo Fisher Scientific Inc.

NYSE:TMO

Medical - Diagnostics & Research

Healthcare
$692.74 +0.96%

+$4.45 today

Market cap
$256.67B
Beta
0.87
P/E (TTM)
25.3
EPS (TTM)
$18.44
Dividend yield
0.39%
52W Low $390.50High $643.99

Volume 1.99M

Average 2.23M

TMO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Thermo Fisher Scientific Inc.NYSE: TMO

Gross Margin · Q3 FY2026 · quarter ended Sep 2026

Gross margin widens to 42.8%

Gross margin was 42.8% in Q3 FY2026, up 1.6 pp from a year earlier. On a trailing-twelve-month basis it was 41.4%, up 1.0 pp year over year. Over 3 fiscal years it narrowed by 1.4 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
42.8%+1.6 pp QoQ
Last fiscal yearDec 2025
40.9%-0.4 pp YoY
LTMSep 2026
41.4%+1.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.6 pp——
1 year-0.4 pp——
3 years-1.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
40.9%
Year-over-year change
-0.4pp

Gross Margin vs competitors

How TMO compares with its peers on the latest reported figures

  • TMO's LTM Sep 2026 gross margin of 41.4% is the lowest of the 10 companies compared; the peer median is 53.7%.
  • Its year-over-year change of +1.0 pp is the highest of 10, against a peer median of -1.1 pp.
  • Over three fiscal years its change of -1.4 pp compares with a peer median of -1.9 pp.
TMO Competitors Peer median
Gross Margin for TMO and competitors
Company Period LTM level YoY 3-year change
TECHBio-Techne CorporationLTM Sep 202665.8% +0.4 pp-2.0 pp
QGENQiagen N.V.LTM Jun 202661.8% -1.1 pp-2.9 pp
DHRDanaher CorporationLTM Sep 202658.6% -2.7 pp+0.2 pp
MTDMettler-Toledo International Inc.LTM Jun 202658.4% -0.2 pp+2.2 pp
AAgilent Technologies, Inc.LTM Jul 202653.7% +0.8 pp-1.9 pp
RVTYRevvity, Inc.LTM Jul 202652.1% -1.9 pp-0.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 202651.9% -0.9 pp-3.9 pp
WATWaters CorporationLTM Jul 202650.8% -8.2 pp-0.2 pp
BRKRBruker CorporationLTM Jun 202646.7% -1.6 pp-5.7 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202641.4% +1.0 pp-1.4 pp
Peer median (excluding TMO) 53.7%-1.1 pp-1.9 pp

Competitors are the stored peer set for TMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue39.21B44.92B42.86B42.88B44.56B
Cost of Revenue19.58B25.9B25.66B25.15B26.32B
Gross Profit19.63B19.01B17.19B17.73B18.24B
Gross Margin50.1%42.3%40.1%41.3%40.9%
Research & Development1.41B1.47B1.34B1.39B1.4B
Selling, General & Admin7.91B9.02B8.41B8.68B8.73B
Operating Expenses9.32B10.49B9.75B10.07B10.13B
Depreciation & Amortization2.59B3.38B3.41B3.11B2.78B
EBITDA11.97B11.94B11.2B11.8B11.47B
EBITDA Margin30.5%26.6%26.1%27.5%25.7%
Operating Income10.32B8.53B7.45B7.66B8.11B
Operating Margin26.3%19.0%17.4%17.9%18.2%
Interest Income43M272M879M1.08B993M
Interest Expense536M726M1.49B1.65B1.42B
Other Income / Expenses(1.48B)(862M)(1.21B)(667M)(842M)
Income Before Tax8.84B7.66B6.24B7B7.27B
Pre-Tax Margin22.5%17.1%14.6%16.3%16.3%
Income Tax Expense1.11B703M284M657M547M
Net Income7.73B6.95B6B6.34B6.74B
Net Margin19.7%15.5%14.0%14.8%15.1%
EPS (Basic)19.6117.7315.5316.5817.77
EPS (Diluted)19.4617.6415.4516.5317.74
Weighted Avg Shares394M392M386M382M376M
Weighted Avg Shares (Diluted)397M394M388M383M377M

Thermo Fisher Scientific Inc.

NYSE:TMO

Intrinsic Alpha fair value

Locked

Current Price

$692.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.